“I maintain that an approval for COVID is the greatest accelerant that we could possibly have for the advancement of this medicine for all other indications.”
Even without an approval for COVID, I think the pandemic accelerated the development of Leronlimab. It’s amazing to think how far we have come in the last eight months.